112 related articles for article (PubMed ID: 2553353)
1. [Evaluation of antipyrine clearance in chronic liver diseases].
Wang JL; Zhang F; Yuan SY
Zhonghua Nei Ke Za Zhi; 1989 May; 28(5):295-7, 315-6. PubMed ID: 2553353
[TBL] [Abstract][Full Text] [Related]
2. Antipyrine clearance in chronic and neoplastic liver diseases: a study of 518 patients.
Grieco A; Castellano R; Matera A; Marcoccia S; Di Rocco P; Ragazzoni E; Vecchio FM; Gasbarrini G
J Gastroenterol Hepatol; 1998 May; 13(5):460-6. PubMed ID: 9641640
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of liver reserve function by ICGR15 detection before hepatectomy for hepatocellular carcinoma].
Lao XM; Zhang YQ; Guan YX; Guo RP; Lin XJ; Yuan YF; Li JQ; Li GH
Ai Zheng; 2004 Oct; 23(10):1213-7. PubMed ID: 15473939
[TBL] [Abstract][Full Text] [Related]
4. Intravenous tryptophan tolerance test for liver function.
Zhu SS; Hu F; Li DG; Jin GQ; Jiang SJ; Lu HM; Li R
Chin Med J (Engl); 1990 Feb; 103(2):146-51. PubMed ID: 2167818
[TBL] [Abstract][Full Text] [Related]
5. [NK activity in various liver diseases--especially the relation between NK activity and reserve function of the liver in liver cirrhosis and hepatocellular carcinoma].
Takagi H; Sakurai S; Uehara M; Yamada S; Kobayashi S
Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2369-74. PubMed ID: 2559127
[TBL] [Abstract][Full Text] [Related]
6. Antipyrine clearance in comparison to conventional liver function tests in hepatitis C virus patients.
Mahmoud M; Abdel-Kader R; Hassanein M; Saleh S; Botros S
Eur J Pharmacol; 2007 Aug; 569(3):222-7. PubMed ID: 17628532
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
Shiota G; Umeki K; Okano J; Kawasaki H
J Med; 1995; 26(5-6):295-308. PubMed ID: 8721905
[TBL] [Abstract][Full Text] [Related]
8. Hepatic parenchymal cell volume and the indocyanine green tolerance test.
Hashimoto M; Watanabe G
J Surg Res; 2000 Aug; 92(2):222-7. PubMed ID: 10896825
[TBL] [Abstract][Full Text] [Related]
9. Changes in antipyrine clearance and platelet count, but not conventional liver tests, correlate with fibrotic change in chronic hepatitis C: value for predicting fibrotic progression.
Coverdale SA; Samarasinghe DA; Lin R; Kench J; Byth K; Khan MH; Crewe E; Liddle C; George J; Farrell GC
Am J Gastroenterol; 2003 Jun; 98(6):1384-90. PubMed ID: 12818285
[TBL] [Abstract][Full Text] [Related]
10. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis.
Sheng QS; Lang R; He Q; Yang YJ; Zhao DF; Chen DZ
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):46-9. PubMed ID: 19208514
[TBL] [Abstract][Full Text] [Related]
11. Does a long pre-operative hospital stay before hepatectomy improve liver dysfunction in HCC patients with chronic liver disease?
Ezaki T; Koyanagi N; Toyomasu T; Ikeda Y; Sugimachi K
Hepatogastroenterology; 1997; 44(14):472-6. PubMed ID: 9164521
[TBL] [Abstract][Full Text] [Related]
12. [Endogenous bile acids in the blood as a functional test in chronic liver diseases. I. Comparison with the antipyrine elimination test].
Habior A
Pol Arch Med Wewn; 1982; 68(3):125-32. PubMed ID: 7170227
[No Abstract] [Full Text] [Related]
13. Assessment of liver function for successful hepatectomy in patients with hepatocellular carcinoma with impaired hepatic function.
Uchiyama K; Mori K; Tabuse K; Ueno M; Ozawa S; Nakase T; Kawai M; Tani M; Tanimura H; Yamaue H
J Hepatobiliary Pancreat Surg; 2008; 15(6):596-602. PubMed ID: 18987929
[TBL] [Abstract][Full Text] [Related]
14. Galactose clearance in patients with hepatocellular carcinoma. Evaluation of effective hepatic blood flow.
Meacci E; Smorlesi C; Chiarantini E; Birardi A; Buzzelli G
Boll Soc Ital Biol Sper; 1987 Jun; 63(6):489-95. PubMed ID: 2820446
[No Abstract] [Full Text] [Related]
15. Antipyrine clearance and its correlation to routine liver function tests in patients with liver disease.
Krausz Y; Zylber-Katz E; Levy M
Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):253-7. PubMed ID: 7450926
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy.
Lau H; Man K; Fan ST; Yu WC; Lo CM; Wong J
Br J Surg; 1997 Sep; 84(9):1255-9. PubMed ID: 9313707
[TBL] [Abstract][Full Text] [Related]
17. [Two-stage multivariant analyses for prediction of hepatic function reserve].
Lu MD; Huang JF; Peng BG
Zhonghua Wai Ke Za Zhi; 1994 Dec; 32(12):745-8. PubMed ID: 7774427
[TBL] [Abstract][Full Text] [Related]
18. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of Doppler waveform of hepatic veins for assessment of hepatic functional reserve.
Oshima K; Kaneko T; Kawase Y; Nakao A
Hepatogastroenterology; 2007; 54(73):180-5. PubMed ID: 17419256
[TBL] [Abstract][Full Text] [Related]
20. [Estimation of hepatic resection volume in hepatocellular carcinoma by ICG(R15) and its relation with postoperative liver failure].
Lao XM; Zhang YQ; Lin XJ; Guo RP; Chen MS; Yuan YF; Li JQ; Li GH
Ai Zheng; 2005 Mar; 24(3):337-40. PubMed ID: 15757537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
